Novavax Inc. (NVAX)
Novavax Statistics
Share Statistics
Novavax has 160.84M shares outstanding. The number of shares has increased by 14.56% in one year.
| Shares Outstanding | 160.84M |
| Shares Change (YoY) | 14.56% |
| Shares Change (QoQ) | 0.41% |
| Owned by Institutions (%) | 64.11% |
| Shares Floating | 146.58M |
| Failed to Deliver (FTD) Shares | 6.57K |
| FTD / Avg. Volume | 0.15% |
Short Selling Information
The latest short interest is 38.07M, so 23.77% of the outstanding shares have been sold short.
| Short Interest | 38.07M |
| Short % of Shares Out | 23.77% |
| Short % of Float | 24.88% |
| Short Ratio (days to cover) | 8.38 |
Valuation Ratios
The PE ratio is -6.53 and the forward PE ratio is 20.61. Novavax's PEG ratio is 0.08.
| PE Ratio | -6.53 |
| Forward PE | 20.61 |
| PS Ratio | 1.79 |
| Forward PS | 2.3 |
| PB Ratio | -1.96 |
| P/FCF Ratio | -12.2 |
| PEG Ratio | 0.08 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Novavax.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.98, with a Debt / Equity ratio of -0.37.
| Current Ratio | 0.98 |
| Quick Ratio | 0.97 |
| Debt / Equity | -0.37 |
| Debt / EBITDA | -2.13 |
| Debt / FCF | -2.3 |
| Interest Coverage | -12.4 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $716.56K |
| Profits Per Employee | $-196.95K |
| Employee Count | 952 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 23.17 |
Taxes
| Income Tax | 10.88M |
| Effective Tax Rate | -6.16% |
Stock Price Statistics
The stock price has increased by 32.16% in the last 52 weeks. The beta is 2.91, so Novavax's price volatility has been higher than the market average.
| Beta | 2.91 |
| 52-Week Price Change | 32.16% |
| 50-Day Moving Average | 7.99 |
| 200-Day Moving Average | 10.44 |
| Relative Strength Index (RSI) | 26.12 |
| Average Volume (20 Days) | 4.32M |
Income Statement
In the last 12 months, Novavax had revenue of 682.16M and earned -187.5M in profits. Earnings per share was -1.23.
| Revenue | 682.16M |
| Gross Profit | 479.42M |
| Operating Income | -248.93M |
| Net Income | -187.5M |
| EBITDA | -108.04M |
| EBIT | -156.54M |
| Earnings Per Share (EPS) | -1.23 |
Balance Sheet
The company has 530.23M in cash and 230.42M in debt, giving a net cash position of 299.81M.
| Cash & Cash Equivalents | 530.23M |
| Total Debt | 230.42M |
| Net Cash | 299.81M |
| Retained Earnings | -5.01B |
| Total Assets | 1.56B |
| Working Capital | -25.47M |
Cash Flow
In the last 12 months, operating cash flow was -87.26M and capital expenditures -13.06M, giving a free cash flow of -100.32M.
| Operating Cash Flow | -87.26M |
| Capital Expenditures | -13.06M |
| Free Cash Flow | -100.32M |
| FCF Per Share | -0.66 |
Margins
Gross margin is 70.28%, with operating and profit margins of -36.49% and -27.49%.
| Gross Margin | 70.28% |
| Operating Margin | -36.49% |
| Pretax Margin | -25.89% |
| Profit Margin | -27.49% |
| EBITDA Margin | -15.84% |
| EBIT Margin | -36.49% |
| FCF Margin | -14.71% |
Dividends & Yields
NVAX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for NVAX is $18.5, which is 208.3% higher than the current price. The consensus rating is "Hold".
| Price Target | $18.5 |
| Price Target Difference | 208.3% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
Stock Splits
The last stock split was on May 10, 2019. It was a backward split with a ratio of 1:20.
| Last Split Date | May 10, 2019 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | -4.12 |
| Piotroski F-Score | 3 |